Back | Next |
home / stock / asmb / asmb message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ASMB News Article - Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advan | whytestocks | investorshangout | 08/18/2021 3:15:49 PM |
whytestocks: $ASMB News Article - Assembly Biosciences to Present Data from HBV Core Inhibitor Progr | whytestocks | investorshangout | 06/09/2021 8:25:49 PM |
$ASMB 1Q21 results: | DewDiligence | investorshub | 05/06/2021 9:41:36 PM |
$ASMB axes ABI-H0731 program: | DewDiligence | investorshub | 02/25/2021 9:27:08 PM |
$ASMB axes microbiome program: | DewDiligence | investorshub | 12/08/2020 10:04:19 PM |
$ASMB seems to be acknowledging that its in-house | DewDiligence | investorshub | 11/16/2020 2:22:19 PM |
* * $ASMB Video Chart 11-06-2020 * * | ClayTrader | investorshub | 11/06/2020 10:10:43 PM |
Good luck! I have no position, FWIW. | DewDiligence | investorshub | 11/06/2020 8:57:39 PM |
Another ticker a week ago$ TCDA did a | Garyst | investorshub | 11/06/2020 8:55:43 PM |
Stock down 68%, much worse than yesterday's AH session. | DewDiligence | investorshub | 11/06/2020 8:16:40 PM |
Is $ASMB now a buy? It depends! See #msg-159346890. | DewDiligence | investorshub | 11/06/2020 8:15:53 PM |
$ASMB 3Q20 results9/30/20 cash=$238M: | DewDiligence | investorshub | 11/05/2020 10:59:28 PM |
$ASMB(-37%/AH)suffers massive phase-2 failure in HBV: | DewDiligence | investorshub | 11/05/2020 10:58:09 PM |
ASMB, $ABUS collaborate on phase-2 HBV trial testing | DewDiligence | investorshub | 08/27/2020 12:36:52 PM |
$ASMB 6/30/20 cash=$226.7M2Q20 burn=$22.4M: | DewDiligence | investorshub | 08/05/2020 10:06:02 PM |
$ASMB(+10%)inks deal with BGNE for Greater-China development/commercialization | DewDiligence | investorshub | 07/20/2020 3:49:24 PM |
ASMB starts phase-2 for second-generation HBV CpAM, $ABT-H2158: | DewDiligence | investorshub | 06/25/2020 3:06:12 PM |
$ASMB 1Q20 results and HBV update | DewDiligence | investorshub | 05/07/2020 10:24:24 PM |
$ASMB 4Q19 results12/31/19 cash=$274M: | DewDiligence | investorshub | 03/04/2020 10:39:41 PM |
* * $ASMB Video Chart 12-12-2019 * * | ClayTrader | investorshub | 12/12/2019 10:36:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
2024-04-07 03:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Four candidates planned to be in clinical development in 2024 with interim data from two studies anticipated by year end Clinical development timelines accelerated for ABI-5366; now anticipating interim data from Phase 1a available in 3Q2024, initiation of Phase 1b in individuals with rec...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...